Tirzepatide Across the Cardiovascular Continuum From HFpEF to cardiorenal protection with a dual GLP-1/GIP agonist. d [Internet]. 2026 Jul. 7 [cited 2026 Jul. 28];4(21):42-3. Available from: https://thediabzen.com/index.php/d/article/view/64